DEUTSCHE BANK AG\ - BIOLINERX LTD ownership

BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 26 filers reported holding BIOLINERX LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BIOLINERX LTD
ValueSharesWeighting
Q4 2018$26,000
-66.7%
61,205
-32.5%
0.00%
Q1 2018$78,000
-73.7%
90,655
-66.8%
0.00%
Q4 2017$297,000
-85.4%
273,095
-85.0%
0.00%
-100.0%
Q3 2017$2,033,000
+353.8%
1,816,701
+242.1%
0.00%
Q2 2017$448,000
+31.0%
531,101
+48.8%
0.00%
Q1 2017$342,000
+74.5%
356,830
+67.0%
0.00%
Q4 2016$196,000
-20.0%
213,6960.0%0.00%
Q3 2016$245,000
+26.3%
213,696
-12.3%
0.00%
Q2 2016$194,000
-21.8%
243,6960.0%0.00%
Q1 2016$248,000
-21.5%
243,6960.0%0.00%
Q4 2015$316,000
-60.6%
243,696
-53.5%
0.00%
-100.0%
Q3 2015$802,000
-53.3%
524,184
-18.9%
0.00%0.0%
Q2 2015$1,718,000
+26.0%
646,1460.0%0.00%0.0%
Q1 2015$1,363,000
+161.1%
646,146
+100.1%
0.00%
Q4 2014$522,000
+76.9%
322,846
+68.3%
0.00%
Q3 2014$295,000
-26.1%
191,8500.0%0.00%
Q2 2014$399,000
-19.7%
191,850
-14.0%
0.00%
Q1 2014$497,000
+22.7%
223,050
+54.6%
0.00%
Q4 2013$405,000
-9.2%
144,250
-29.5%
0.00%
Q3 2013$446,000204,5800.00%
Other shareholders
BIOLINERX LTD shareholders Q1 2016
NameSharesValueWeighting ↓
BVF INC/IL 1,501,000$2,432,0000.47%
Senvest Management, LLC 2,278,995$3,692,0000.26%
Opaleye Management Inc. 250,000$405,0000.20%
SABBY MANAGEMENT, LLC 928,758$1,505,0000.05%
Benchmark Capital Advisors 40,000$65,0000.04%
Orbimed Advisors 1,135,000$1,839,0000.02%
NEXT Financial Group, Inc 28,500$46,0000.02%
Cutter & CO Brokerage, Inc. 10,000$16,0000.01%
Tower Research Capital LLC (TRC) 110$00.00%
Renaissance Technologies 26,878$44,0000.00%
View complete list of BIOLINERX LTD shareholders